Literature DB >> 19251903

Antibody-mediated immobilization of Cryptococcus neoformans promotes biofilm formation.

Emma J Robertson1, Arturo Casadevall.   

Abstract

Most microbes, including the fungal pathogen Cryptococcus neoformans, can grow as biofilms. Biofilms confer upon microbes a range of characteristics, including an ability to colonize materials such as shunts and catheters and increased resistance to antibiotics. Here, we provide evidence that coating surfaces with a monoclonal antibody to glucuronoxylomannan, the major component of the fungal capsular polysaccharide, immobilizes cryptococcal cells to a surface support and, subsequently, promotes biofilm formation. We used time-lapse microscopy to visualize the growth of cryptococcal biofilms, generating the first movies of fungal biofilm growth. We show that when fungal cells are immobilized using surface-attached specific antibody to the capsule, the initial stages of biofilm formation are significantly faster than those on surfaces with no antibody coating or surfaces coated with unspecific monoclonal antibody. Time-lapse microscopy revealed that biofilm growth was a dynamic process in which cells shuffled position during budding and was accompanied by emergence of planktonic variant cells that left the attached biofilm community. The planktonic variant cells exhibited mobility, presumably by Brownian motion. Our results indicate that microbial immobilization by antibody capture hastens biofilm formation and suggest that antibody coating of medical devices with immunoglobulins must exclude binding to common pathogenic microbes and the possibility that this effect could be exploited in industrial microbiology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19251903      PMCID: PMC2675221          DOI: 10.1128/AEM.02846-08

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  31 in total

Review 1.  Bacterial biofilms: a common cause of persistent infections.

Authors:  J W Costerton; P S Stewart; E P Greenberg
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

2.  Medical importance of biofilms in Candida infections.

Authors:  L Julia Douglas
Journal:  Rev Iberoam Micol       Date:  2002-09       Impact factor: 1.044

Review 3.  Candida biofilms on implanted biomaterials: a clinically significant problem.

Authors:  Gordon Ramage; José Pedro Martínez; José Luis López-Ribot
Journal:  FEMS Yeast Res       Date:  2006-11       Impact factor: 2.796

4.  Cryptococcus neoformans cells in biofilms are less susceptible than planktonic cells to antimicrobial molecules produced by the innate immune system.

Authors:  Luis R Martinez; Arturo Casadevall
Journal:  Infect Immun       Date:  2006-11       Impact factor: 3.441

5.  Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance.

Authors:  J Chandra; D M Kuhn; P K Mukherjee; L L Hoyer; T McCormick; M A Ghannoum
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

Review 6.  Candida infections of medical devices.

Authors:  Erna M Kojic; Rabih O Darouiche
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

Review 7.  Escherichia coli biofilms.

Authors:  C Beloin; A Roux; J M Ghigo
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

8.  Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro.

Authors:  Luis R Martinez; Arturo Casadevall
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

9.  Ventriculoatrial shunt infection due to Cryptococcus neoformans: an ultrastructural and quantitative microbiological study.

Authors:  T J Walsh; R Schlegel; M M Moody; J W Costerton; M Salcman
Journal:  Neurosurgery       Date:  1986-03       Impact factor: 4.654

10.  Antibody to Cryptococcus neoformans glucuronoxylomannan inhibits the release of capsular antigen.

Authors:  Luis R Martinez; Dariush Moussai; Arturo Casadevall
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

View more
  7 in total

1.  Antifungal and Antibiofilm In Vitro Activities of Ursolic Acid on Cryptococcus neoformans.

Authors:  Wen-Jing Wang; Chan-Chan Liu; Yan-Tong Li; Miao-Qian Li; Yu-Ting Fu; Xin-Chen Li; Wei-Dong Qian
Journal:  Curr Microbiol       Date:  2022-08-16       Impact factor: 2.343

2.  Fungal cell wall dynamics and infection site microenvironments: signal integration and infection outcome.

Authors:  Kelly M Shepardson; Robert A Cramer
Journal:  Curr Opin Microbiol       Date:  2013-04-15       Impact factor: 7.934

3.  EDTA inhibits biofilm formation, extracellular vesicular secretion, and shedding of the capsular polysaccharide glucuronoxylomannan by Cryptococcus neoformans.

Authors:  Emma J Robertson; Julie M Wolf; Arturo Casadevall
Journal:  Appl Environ Microbiol       Date:  2012-08-31       Impact factor: 4.792

4.  In Vitro Analysis of Metabolites Secreted during Infection of Lung Epithelial Cells by Cryptococcus neoformans.

Authors:  Kah Leong Liew; Jap Meng Jee; Ivan Yap; Phelim Voon Chen Yong
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

5.  Virulence of Cryptococcus sp. Biofilms In Vitro and In Vivo using Galleria mellonella as an Alternative Model.

Authors:  Tatiane Benaducci; Janaina de C O Sardi; Natalia M S Lourencetti; Liliana Scorzoni; Fernanda P Gullo; Suélen A Rossi; Jaqueline B Derissi; Márcia C de Azevedo Prata; Ana M Fusco-Almeida; Maria J S Mendes-Giannini
Journal:  Front Microbiol       Date:  2016-03-09       Impact factor: 5.640

6.  Geometrical Distribution of Cryptococcus neoformans Mediates Flower-Like Biofilm Development.

Authors:  William Lopes; Mendeli H Vainstein; Glauber R De Sousa Araujo; Susana Frases; Charley C Staats; Rita M C de Almeida; Augusto Schrank; Lívia Kmetzsch; Marilene H Vainstein
Journal:  Front Microbiol       Date:  2017-12-19       Impact factor: 5.640

Review 7.  Cryptococcal Traits Mediating Adherence to Biotic and Abiotic Surfaces.

Authors:  Emma Camacho; Arturo Casadevall
Journal:  J Fungi (Basel)       Date:  2018-07-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.